Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
This is a Phase 3 efficacy and safety study of CD07805/47 topical gel in subjects with facial
erythema associated with rosacea. The study hypothesis is that CD07805/47 gel, applied
topically once daily is more efficacious than vehicle and provides an acceptable safety
profile in the treatment of facial erythema associated with rosacea.